Initial results of a positron tomograph for prostate imaging

IEEE Transactions on Nuclear Science

Volumn 53, Issue 5, 2006, Pages 2653-2659

  Huber, J S ^a,b   Choong, W S ^a,b   Moses, W W ^a,b   Qi, J ^a,c   Hu, J ^a,b   Wang, G C ^a,b   Wilson, D ^b   Oh, S ^b   Huesman, R H ^a,b   Derenzo, S E ^a,b   Budinger, T F ^a,b  

^a IEEE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c University of California   (United States)

Author keywords

Positron emission tomography (PET); Prostate cancer

Indexed keywords

CTI DATA ACQUISITION ELECTRONICS; DETECTOR BANKS; PHANTOMS; RESOLUTION DEGRADATION;

CALIBRATION; COMPUTERIZED TOMOGRAPHY; DATA ACQUISITION; DETECTORS; IMAGE RECONSTRUCTION; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; TUMORS;

MEDICAL IMAGING;

EID: 33750426316     PISSN: 00189499     EISSN: None     Source Type: Journal    
DOI: 10.1109/TNS.2006.882796     Document Type: Article

References (34)

1. Cancer Facts and Figures 2005, American Cancer Society. Atlanta, GA [Online], Available: http://www.cancer.org/downloads/STT/CAFF2005f4PWSecured.pdf
2. Clinical Practice Guidelines in Oncology: Prostate Cancer, National Comprehensive Cancer Clinic [Online], Available: http://www.nccn.org
3. NIH Senior Health: Prostate Cancer - Symptoms and Diagnosis, National Cancer Institute [Online], Available: http://nihseniorhealth.gov/prostatecancer/ symptomsanddiagnosis/07.html
4. Prostate Cancer, PDQ-NCI's Comprehensive Cancer Database, Bethesda, MD: National Cancer Institute [Online], Available: http://www.cancer.gov/ cancertopics/types/prostate
5. J. S. Huber, "Conceptual design of a compact positron tomograph for prostate imaging," IEEE Trans. Nucl. Sci., vol. 48, pp. 1506-1511, 2001.
6. C. Schiepers, "Factor analysis in prostate cancer: Delineation of organ structures and automatic generation of in- and output functions," IEEE Trans. Nucl. Sci., vol. 49, pp. 2338-2343, 2002.
7. J. Qi, "Septa design for a prostate specific PET camera," IEEE Trans. Nucl. Sci., vol. 52, no. 1, pp. 107-113, 2004.
8. T. G. Turkington, "PET prostate imaging with small planar detectors," in Proc. IEEE NSS and MIC Conf. Rec., Rome, Italy, 2004, pp. 2806-2809.
9. J. Hu, J. Qi, J. S. Huber, W. W. Moses, and R. H. Huesman, "MAP image reconstruction for arbitrary geometry PET systems with application to a prostate-specific scanner," in Proc. Int. Meeting Fully Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine, Salt Lake City, UT, 2005, pp. 416-420.
10. G. Llosa, "Development of a pre-clinical compton probe prototype for prostate imaging," in Proc. IEEE NSS and MIC Conf. Rec., Rome, Italy, 2004, pp. 4168-4171.
11. L. Zhang, Y. Dewaraja, W. L. Rogers, and N. H. Clinthorne, "Performance evaluation of compton probe and SPECT in lesion detection," in Proc. IEEE NSS and MIC Conf. Rec., Rome, Italy, 2004, pp. 2379-2382.
12. Y. Seo, J. Kurhanewicz, L. F. Franc, R. A. Hawkins, and B. H. Hasegawa, "Improved prostate cancer imaging with SPECT/CT and MRI/MRS," in Proc. IEEE NSS and MIC Conf. Rec., Rome, Italy, 2004, pp. 2402-2406.
13. J. Kurhanewicz, "Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution," Radiology, vol. 198, pp. 795-805, 1996.
14. J. Kurhanewicz, D. B. Vigneron, R. G. Males, K. Yu, and H. Hricak, "The prostate: Magnetic resonance imaging and spectroscopy: Present and future," in Radiologic Clinics of North America, H. Hricak and P. R. Carroll, Eds. New York: W. B. Saunders, 2000, pp. 115-138, New York.
15. T. Hara, N. Kosaka, N. Shinoura, and T. Kondo, "PET imaging of brain tumor with [methyl-C11]choline," J. Nucl. Med., vol. 38, pp. 842-7, 1997.
16. N. Shinoura, "Brain tumors: detection with C-11 choline PET," Radiology, vol. 202, pp. 497-503, 1997.
17. T. Hara, N. Kosaka, and H. Kishi, "PET imaging of prostate cancer using carbon-11-choline," J. Nucl. Med., vol. 39, pp. 990-5, 1998.
18. T. Hara, N. Kosaka, T. Kondo, H. Kishi, and O. Kobori, "Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C-11]choline," J. Nucl. Med., vol. 38, no. suppl, p. 250P, 1997, abstract.
19. T. Hara, K. Inagaki, N. Kosaka, and T. Morita, "Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11 C-choline PET," J. Nucl. Med., vol. 41, pp. 1507-13, 2000.
20. I. J. Jong, "Imaging of bladder cancer using carbon-11 choline positron emission tomography," J. Nucl. Med., vol. 41, no. 5 Suppl, p. 74, 2000.
21. J. Kotzerke, "Carbon-11 choline positron emission tomography (PET) of prostate cancer-first clinical experience," J. Nucl. Med., vol. 41, no. 5 Suppl, p. 74, 2000.
22. J. Kotzerke, "Experience with carbon-11 choline positron emission tomography in prostate carcinoma," Eur. J. Nucl Med., vol. 27, pp. 1415-9, 2000.
23. T. Kato, "Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: Comparison with prostate cancer," Eur. J. Nucl. Med. Mol. Imaging, vol. 29, pp. 1492-1495, 2002.
24. N. Oyama, "11C-acetate PET imaging of prostate cancer: Detection of recurrent disease at PSA relapse," J. Nucl. Med., vol. 44, pp. 556-558, 2003.
25. E. Fricke, "Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients," Bur. J. Nucl. Med. Mol. Imaging, vol. 30, pp. 607-610, 2003.
26. I. Osman, "C-11 methionine and F-18 PET imaging: use in the evaluation of progressive prostate cancer," Proc. Am. Soc. Clin. Oncol., vol. 17, p. 1203, 1998, abstract.
27. H. A. Macapinlac, "Differential metabolism and pharmacokinetics of L- [1-C-11]methionine and 2-[F-18]ftuoro-2-deoxy-D-glucose (FDG) in androgen independent prostate cancer," Clin. Positron Imaging, vol. 2, pp. 173-81, 1999.
28. R. Nunez, "Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer," J. Nucl. Med., vol. 43, no. 1, pp. 46-55, 2002.
29. G. Toth, "Detection of prostate cancer with HC-methionine positron emission tomography," J. Urol., vol. 173, no. 1, pp. 66-69, 2005.
30. M. K. Haseman, N. L. Reed, and S. A. Rosenthal, "Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation," Clin. Nucl. Med., vol. 21, pp. 704-13, 1996.
31. P. F. Faulhaber, D. B. Sodee, E. Echt, and J. K. O'Donnell, "Staging of Prostate Adenocarcinoma, comparison of FDG Dedicated PET and In-111 Capromab Pendetide," J. Nucl. Med., vol. 41, p. 116, 2000, abstract.
32. T. R. Degrade, "Synthesis and evaluation of F18-labeled choline as an oncologic tracer for positron emission tomography: Initial findings in prostate cancer," Cancer Research, vol. 61, no. 1, pp. 110-117, 2001.
33. T. R. Degrado, "Synthesis and evaluation of F18-labeled choline analogs as oncologic PET tracers," J. Nuc. Med., vol. 42, pp. 1805-1814, 2001.
34. R. H. Huesman, "List mode maximum likelihood reconstruction applied to positron emission mammography with irregular sampling.," IEEE Trans. Med. Imag., vol. 19, pp. 532-537, 2000.